Your browser doesn't support javascript.
loading
Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia.
Takahashi, Naoto; Miura, Masatomo; Scott, Stuart A; Kagaya, Hideaki; Kameoka, Yoshihiro; Tagawa, Hiroyuki; Saitoh, Hirobumi; Fujishima, Naohito; Yoshioka, Tomoko; Hirokawa, Makoto; Sawada, Kenichi.
Affiliation
  • Takahashi N; Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
J Hum Genet ; 55(11): 731-7, 2010 Nov.
Article in En | MEDLINE | ID: mdl-20720558
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Piperazines / Pyrimidines / Leukemia, Myeloid, Chronic-Phase / ATP-Binding Cassette Transporters / Polymorphism, Single Nucleotide / Neoplasm Proteins / Antineoplastic Agents Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Hum Genet Journal subject: GENETICA MEDICA Year: 2010 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Piperazines / Pyrimidines / Leukemia, Myeloid, Chronic-Phase / ATP-Binding Cassette Transporters / Polymorphism, Single Nucleotide / Neoplasm Proteins / Antineoplastic Agents Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Hum Genet Journal subject: GENETICA MEDICA Year: 2010 Type: Article Affiliation country: Japan